Literature DB >> 10512154

Choosing negative symptom instruments: issues of representation and redundancy.

J Welham1, T Stedman, A Clair.   

Abstract

Assuming that the negative syndrome in schizophrenia may be multidimensional, this study examines how conclusions about the structure of negative symptoms may be influenced by the particular rating scale used, the level of data reduction used (such as total, subscale and individual item scores), and also the type of data analyses used to compare scales. Forty-seven subjects with RDC schizophrenia were rated on three instruments: the negative symptom subscale of the BPRS (BPRS-WR); the negative symptom subscale of the PANSS (PANSS-NS); and the SANS. Comparisons were made of different levels of data reduction and different methods of analysis, which included bivariate correlation, bi-multivariate canonical correlation and redundancy analysis. We found that while the total scores from all three scales were highly correlated and therefore highly redundant, both the individual items and subscale scores from the SANS contained information independent of the BPRS-WR, and also, to a lesser extent, of the PANSS-NS. When the BPRS-WR was correlated with either the SANS or the PANSS-NS, one strong canonical variate (CV) emerged, on which all or most items loaded, particularly the affective items. When the SANS and PANSS-NS were correlated, this component again emerged along with three less strong but interpretable components. When examining the non-symmetrical redundancy, we found that the BPRS-WR variates explained 40% of the SANS variance, while conversely the SANS variates explained 80% of the BPRS-WR variance. The PANSS-NS variates were found to explain 58% of the SANS variance, while the SANS variates explained 85% of the PANSS-NS variance. Finally, the PANSS-NS variates explained 79% of the BPRS-WR variance, while conversely the BPRS-WR variates explained 54% of the PANSS-NS variance. AH three scales appear to measure a single general 'affective' component of the negative syndrome, while the PANSS-NS and the SANS also cover additional components which identify cognitive, anergic and social dimensions. This extra information is lost, however, if inappropriate data reduction and/or statistical analyses are used. The fact that the three instruments predicted the various dimensions of the negative syndrome to different degrees suggests that the best choice of a negative scale depends on the type of information required. Nevertheless, further examination of how negative symptom scales cover the multi-dimensional nature of the negative syndrome is required.

Entities:  

Mesh:

Year:  1999        PMID: 10512154     DOI: 10.1016/s0165-1781(99)00042-6

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.

Authors:  Daniel Fulford; Rahel Pearson; Barbara K Stuart; Melissa Fisher; Daniel H Mathalon; Sophia Vinogradov; Rachel L Loewy
Journal:  Psychiatry Res       Date:  2014-08-01       Impact factor: 3.222

2.  Apathy, poor verbal memory and male gender predict lower psychosocial functioning one year after the first treatment of psychosis.

Authors:  Ann Faerden; Elizabeth Ann Barrett; Ragnar Nesvåg; Svein Friis; Arnstein Finset; Stephen R Marder; Joseph Ventura; Ole A Andreassen; Ingrid Agartz; Ingrid Melle
Journal:  Psychiatry Res       Date:  2013-03-13       Impact factor: 3.222

3.  Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia.

Authors:  Mario Quarantelli; Olga Palladino; Anna Prinster; Vittorio Schiavone; Barbara Carotenuto; Arturo Brunetti; Angela Marsili; Margherita Casiello; Giovanni Muscettola; Marco Salvatore; Andrea de Bartolomeis
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

4.  Brain structural signatures of negative symptoms in depression and schizophrenia.

Authors:  Jie-Yu Chuang; Graham K Murray; Antonio Metastasio; Nuria Segarra; Roger Tait; Jenny Spencer; Hisham Ziauddeen; Robert B Dudas; Paul C Fletcher; John Suckling
Journal:  Front Psychiatry       Date:  2014-08-27       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.